Hey Stayso
Genentech doesn’t have to worry about any capital requirements with gdc0084
imo
Milestone payment due on phase 11b without worrying about the $20m or so estimated cost and also hasn’t any dilution concerns etc
research developing own drugs vs those purchased on licence agreements
dyor